GemPharmatech Co., Ltd. (SHA:688046)

GemPharmatech Revenue

GemPharmatech had revenue of 251.47M CNY in the quarter ending June 30, 2026, with 23.30% growth. This brings the company's total for the last twelve months to 878.13M, up 21.75% year-over-year. In the year 2025, GemPharmatech had annual revenue of 793.39M with 15.51% growth. That makes GemPharmatech the 20,609th largest company in the world by revenue and 3,769th in China.

• Revenue (ttm): 878.13M
• Revenue Growth: +21.75%
• P/S Ratio: 12.94
• Revenue / Employee: 518.99K
• Employees: 1,692
• Market Cap: 11.37B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Commercial Mouse Model Sales 438.77M 55.3%
• Functional Efficacy Business 200.19M 25.2%
• Custom Breeding Business 83.99M 10.6%
• Model Creation Business 47.48M 6.0%
• Agent Import and Export and Others 22.24M 2.8%
• Unallocated Other Operations 723.07K 0.1%

By Geography

Chart

• China 640.78M 80.8%
• Overseas 151.88M 19.2%

Fiscal year ended Dec 31, 2025 See the full GemPharmatech breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	793.39M	106.55M	15.51%
Dec 31, 2024	686.84M	64.65M	10.39%
Dec 31, 2023	622.19M	105.64M	20.45%
Dec 31, 2022	516.55M	122.76M	31.17%
Dec 31, 2021	393.79M	131.87M	50.35%

Data Source: S&P Global Market Intelligence Last updated: Aug 19, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 20, 2026

Data Sources Report a data error